EFFICACY OF OZANIMOD AS AN INDUCTION THERAPY IN ADVANCED THERAPY–NAIVE ULCERATIVE COLITIS PATIENTS SUBOPTIMALLY CONTROLLED ON CONVENTIONAL TREATMENTS

Peter Irving  ¹     Millie Long  ²     Britta Siegmund  ³     Geert D’Haens  ⁴     Irina Blumenstein  ⁵     Anjali Jain  ⁶     Hsiuanlin Wu  ⁶     Mark Osterman  ⁶     Douglas C. Wolf  ⁷     David T. Rubin  ^8    
1 Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom
² UNC Chapel Hill, Chapel Hill, United States
³ Charité – Universitätsmedizin Berlin, Berlin, Germany
⁴ Amsterdam University Medical Center, Amsterdam, Netherlands
⁵ Goethe University Hospital, Frankfurt, Germany
⁶ Bristol Myers Squibb, Princeton, United States
⁷ Center for Crohn’s Disease & Ulcerative Colitis, Atlanta Gastroenterology Associates, Atlanta, United States
⁸ University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, United States

Topic
IBD

Session
Traffic control in IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)